stage ivb lung cancer ajcc v8

Showing 51 - 75 of 81

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lung Carcinoma, Metastatic Malignant Tumor in the Lung, Stage IV Lung Cancer AJCC v8 Trial in Palo Alto (procedure, drug, other)

Active, not recruiting
  • Lung Carcinoma
  • +4 more
  • Near-Infrared Fluorescence Imaging
  • +3 more
  • Palo Alto, California
    Stanford University, School of Medicine
Jun 21, 2022

Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Portland (Best Practice,

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +15 more
  • Best Practice
  • +2 more
  • Portland, Oregon
  • +1 more
Jun 8, 2022

Malignant Female Reproductive System Tumor, Stage 0 Lung Cancer AJCC v8, Stage I Lung Cancer AJCC v8 Trial in Duarte

Active, not recruiting
  • Malignant Female Reproductive System Neoplasm
  • +16 more
  • Educational Intervention
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Advanced Lung Carcinoma, Metastatic Malignant Female Reproductive System Tumor, Stage III Lung Cancer AJCC v8 Trial in Duarte

Active, not recruiting
  • Advanced Lung Carcinoma
  • +8 more
  • Educational Intervention
  • Duarte, California
    City of Hope Medical Center
Jun 3, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Solid Tumor Trial in

Suspended
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 23, 2022

Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,

Withdrawn
  • Lung Non-Small Cell Carcinoma
  • +12 more
  • (no location specified)
May 24, 2022

Lung Non-Small Cell Carcinoma, Positive Surgical Margin, Resected Mass Trial in Buffalo (Quality-of-Life Assessment,

Recruiting
  • Lung Non-Small Cell Carcinoma
  • +9 more
  • Quality-of-Life Assessment
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 2, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 27, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Carcinoma Trial in Columbus (Health

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +7 more
  • Health Education
  • Questionnaire Administration
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 18, 2022

Advanced Lung Carcinoma, Metastatic Lung Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Columbus (Behavioral, Psychological or

Recruiting
  • Advanced Lung Carcinoma
  • +4 more
  • Behavioral, Psychological or Informational Intervention
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 18, 2022

Metastatic Lung Adenocarcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Adenocarcinoma Trial in United States

Recruiting
  • Metastatic Lung Adenocarcinoma
  • +6 more
  • Anchorage, Alaska
  • +466 more
Apr 18, 2022

Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Recurrent Lung Small Cell Carcinoma Trial in

Recruiting
  • Metastatic Lung Small Cell Carcinoma
  • +5 more
  • Memantine Hydrochloride
  • +3 more
  • Phoenix, Arizona
  • +83 more
Apr 8, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +129 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Apr 8, 2022

Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma

Not yet recruiting
  • Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8
  • +45 more
  • Internet-Based Intervention
  • +2 more
  • Manhasset, New York
  • +3 more
Mar 30, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Tumor, Metastatic Neuroendocrine Carcinoma Trial in United

Recruiting
  • Metastatic Lung Small Cell Carcinoma
  • +16 more
  • Phoenix, Arizona
  • +10 more
Mar 25, 2022

Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +4 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Mar 8, 2022

Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III

Terminated
  • Locally Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +9 more
  • Bintrafusp Alfa
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 4, 2022

Lung Carcinoid Tumor, Lung Non-Small Cell Carcinoma, Metastatic Lung Carcinoma Trial in Houston (Cone-Beam Computed Tomography,

Completed
  • Lung Carcinoid Tumor
  • +5 more
  • Cone-Beam Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 14, 2022

Advanced Malignant Solid Tumor, Extensive Stage Lung Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Los Angeles

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +8 more
  • Atezolizumab
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Feb 7, 2022

Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial (Fluorine

Withdrawn
  • Advanced Lung Non-Small Cell Carcinoma
  • +8 more
  • Fluorine F 18 Ara-G
  • (no location specified)
Jan 24, 2022

Advanced Lung Carcinoma, Advanced Malignant Solid Tumor, Malignant Adrenal Gland Tumor Trial in Houston (Anti-CTLA4 Monoclonal

Recruiting
  • Advanced Lung Carcinoma
  • +16 more
  • Anti-CTLA4 Monoclonal Antibody BMS-986218
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Pembrolizumab
  • Ramucirumab
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 22, 2021

Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 Trial in Scottsdale,

Active, not recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +7 more
  • Scottsdale, Arizona
  • +2 more
Nov 3, 2021

Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial (Carboplatin, Durvalumab,

Withdrawn
  • Lung Non-Small Cell Carcinoma
  • +4 more
  • (no location specified)
Oct 26, 2021